Journal
JOURNAL OF VIROLOGY
Volume 86, Issue 18, Pages 10221-10225Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.00882-12
Keywords
-
Categories
Funding
- Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research [5U54AI057160]
- National Institutes of Health [DK081817, AI065535]
Ask authors/readers for more resources
We have examined the underlying mechanism of hepatitis C virus (HCV)-mediated IFITM1 regulation. IFITM1 is a potential target of miR-130a. Our results demonstrated that miR-130a expression was significantly higher in HCV-infected hepatocytes and liver biopsy specimens than in controls. Introduction of anti-miR-130a in hepatocytes increased IFITM1 expression. Hepatocytes stably expressing IFITM1 reduced HCV replication. Together, these results suggested that HCV infection of hepatocytes upregulates miR-130a and that use of anti-miR-130a may have potential for restriction of HCV replication.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available